Ahsan MJ - Search Results

1

Hydrazones as a privileged structural linker in antitubercular agents: a review.

Mathew B, Suresh J, Ahsan MJ, Mathew GE, Usman D, Subramanyan PN, Safna KF, Maddela S. Mathew B, et al. Among authors: ahsan mj. Infect Disord Drug Targets. 2015;15(2):76-88. doi: 10.2174/1871526515666150724104411. Infect Disord Drug Targets. 2015. PMID: 26205803 Review.

2

Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues.

Ahsan MJ, Samy JG, Soni S, Jain N, Kumar L, Sharma LK, Yadav H, Saini L, Kalyansing RG, Devenda NS, Prasad R, Jain CB. Ahsan MJ, et al. Bioorg Med Chem Lett. 2011 Sep 15;21(18):5259-61. doi: 10.1016/j.bmcl.2011.07.035. Epub 2011 Jul 19. Bioorg Med Chem Lett. 2011. PMID: 21807509

3

Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents.

Ahsan MJ, Samy JG, Khalilullah H, Nomani MS, Saraswat P, Gaur R, Singh A. Ahsan MJ, et al. Bioorg Med Chem Lett. 2011 Dec 15;21(24):7246-50. doi: 10.1016/j.bmcl.2011.10.057. Epub 2011 Oct 20. Bioorg Med Chem Lett. 2011. PMID: 22071303

4

Tuberculosis vaccines: hopes and hurdles.

Ahsan MJ, Garg SK, Vashistha B, Sharma P. Ahsan MJ, et al. Infect Disord Drug Targets. 2013 Oct;13(5):318-21. doi: 10.2174/1871526513666131201125513. Infect Disord Drug Targets. 2013. PMID: 24304353 Review.

5

Tuberculosis: current treatment, diagnostics, and newer antitubercular agents in clinical trials.

Ahsan MJ, Ansari MY, Yasmin S, Jadav SS, Kumar P, Garg SK, Aseri A, Khalilullah H. Ahsan MJ, et al. Infect Disord Drug Targets. 2015;15(1):32-41. doi: 10.2174/1871526514666140923153329. Infect Disord Drug Targets. 2015. PMID: 25246035 Review.

6

Molecular recognisation of 3a, 4-dihydro-3-H-indeno [1, 2-C] pyrazole-2- carboxamide/carbothioamide anticonvulsant analogues towards GABA-aminotransferase- an in silico approach.

Mathew B, Ahsan MJ. Mathew B, et al. Among authors: ahsan mj. Cent Nerv Syst Agents Med Chem. 2014;14(1):39-42. doi: 10.2174/1871524914666141003125308. Cent Nerv Syst Agents Med Chem. 2014. PMID: 25277157

7

Synthesis and antimycobacterial evaluation of novel 5,6-dimethoxy-1-oxo-2,5-dihydro-1H-2-indenyl-5,4-substituted phenyl methanone analogues.

Ali MA, Samy JG, Manogaran E, Sellappan V, Hasan MZ, Ahsan MJ, Pandian S, ShaharYar M. Ali MA, et al. Among authors: ahsan mj. Bioorg Med Chem Lett. 2009 Dec 15;19(24):7000-2. doi: 10.1016/j.bmcl.2009.10.034. Epub 2009 Oct 13. Bioorg Med Chem Lett. 2009. PMID: 19879757

8

Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues.

Ahsan MJ, Samy JG, Dutt KR, Agrawal UK, Yadav BS, Vyas S, Kaur R, Yadav G. Ahsan MJ, et al. Bioorg Med Chem Lett. 2011 Aug 1;21(15):4451-3. doi: 10.1016/j.bmcl.2011.06.018. Epub 2011 Jun 17. Bioorg Med Chem Lett. 2011. PMID: 21733688

9

Synthesis and antimycobacterial evaluation of 3a,4-dihydro-3H-indeno [1,2-c] pyrazole-2-carboxamide analogues.

Ahsan MJ, Samy JG, Khalilullah H, Bakht MA, Hassan MZ. Ahsan MJ, et al. Eur J Med Chem. 2011 Nov;46(11):5694-7. doi: 10.1016/j.ejmech.2011.09.035. Epub 2011 Sep 29. Eur J Med Chem. 2011. PMID: 21978838

10

Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues.

Ahsan MJ, Samy JG, Jain CB, Dutt KR, Khalilullah H, Nomani MS. Ahsan MJ, et al. Bioorg Med Chem Lett. 2012 Jan 15;22(2):969-72. doi: 10.1016/j.bmcl.2011.12.014. Epub 2011 Dec 8. Bioorg Med Chem Lett. 2012. PMID: 22197387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters